Stay updated on Aducanumab for Early Alzheimer's: Clinical Trial

Sign up to get notified when there's something new on the Aducanumab for Early Alzheimer's: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Aducanumab for Early Alzheimer's: Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.3, replacing the previous Revision: v3.6.0, indicating an updated internal build of the study details page.
    Difference
    0.0%
    Check dated 2026-06-30T02:20:29.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    The page now displays that recruitment is closed with a 'No longer looking for participants' notice. New help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and a minor formatting change was made to the Interventions label (Intervention / Treatment → Intervention/Treatment) along with a revision version update from v3.5.5 to v3.6.0.
    Difference
    0.2%
    Check dated 2026-06-15T19:44:33.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page version was updated from v3.5.4 to v3.5.5. This appears to be a minor maintenance update to the page.
    Difference
    0.0%
    Check dated 2026-06-08T16:46:53.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    A new reference to a 2025 publication by Cummings et al. evaluating cognitive, functional, and behavioral effects observed in EMERGE (the aducanumab Phase 3 trial) was added to the Publications section.
    Difference
    0.0%
    Check dated 2026-05-25T10:23:45.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.3 to v3.5.4, signaling a minor update to the page.
    Difference
    0.0%
    Check dated 2026-05-18T04:01:20.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    The entry for Malmö, Sweden, 20502 replaces the earlier Malmo, Sweden, 20502 in the Contacts and Locations section. This corrects the city name spelling and adds the proper diacritic.
    Difference
    0.0%
    Check dated 2026-05-04T01:17:00.000Z thumbnail image

Stay in the know with updates to Aducanumab for Early Alzheimer's: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Aducanumab for Early Alzheimer's: Clinical Trial page.